Welcome to Acne Treatment Guide
treatment for acne vulgaris Links
Acne vulgaris: More than skin deep
Current Opinions for the topical treatment of acne vulgaris. ... Treatment of
Acne Vulgaris and Prevention of Acne Scarring: Canadian Consensus Guidelines. ...
Use of Systemic Agents in the Treatment of Acne Vulgaris - October ...
Effective treatment of acne vulgaris can prevent emotional and physical scarring.
... Isotretinoin for the treatment of acne vulgaris: which factors may ...
AllRefer Health - Acne Treatment (Acne Vulgaris, Cystic Acne, Pimples)
Acne (Acne Vulgaris, Cystic Acne, Pimples) information center covers Treatment.
Diagnosis and Treatment of Acne - May 1, 2004 - American Family ...
Doxycycline (eg, Vibramycin, Doryx) frequently is used to treat moderate to severe
acne vulgaris. However, associated photosensitivity may limit its ...
eMedicine - Acne Vulgaris : Article by Julie C Harper, MD
Drug Category: Antibiotics -- Topical and systemic antibiotics used in the
treatment of acne vulgaris are directed at P acnes. ...
Acne Vulgaris Treatment – Quick Acne Treatment!
100% natural acne vulgaris treatment. See major improvement within just 7 days.
Guidelines of Care for Acne Vulgaris
Rational therapy for acne vulgaris: an update on topical treatment. ...
Oral spironolactone: an effective treatment for acne vulgaris in women. ...
treatment for acne vulgaris News
Arcutis Pharmaceuticals Announces FDA Approval of Acanya Gel for the Treatment of Acne (Business Wire via Yahoo! Finance)
REDWOOD CITY, Calif.----Arcutis Pharmaceuticals, a privately held specialty pharmaceutical organization focusing in medical dermatology, announced today that the United States Food and Drug Administration has approved the new drug application of Acanya™ Gel for the once-daily treatment of acne vulgaris in patients 12 years and older.
Read more...Obagi Medical Products Reports Third Quarter 2008 Financial Results (Business Wire via Yahoo! Finance)
LONG BEACH, Calif.----Obagi Medical Products, Inc. , a leader in topical aesthetic and therapeutic skin health systems, today reported financial results for the third quarter and nine months ended September 30, 2008.
Read more...ELASTIderm Eye Treatment Regenerates Elastic Fibers In Skin Around The Eyes, New Study Finds (Medical News Today)
Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announced today the publication of a study of its copper-zinc malonate eye treatment ELASTIderm™ in the September 2008 issue of Experimental Dermatology, a premier journal of investigative dermatology.
Read more...Dusa reports results from Phase IIb acne trial (Pharmaceutical Business Review)
Dusa Pharmaceuticals, an integrated dermatology pharmaceutical company, has announced results from its Phase IIb clinical trial to compare the safety and efficacy of photodynamic therapy using the companys Blu-U brand light plus vehicle containing Levulan to that of photodynamic therapy using the Blu-U plus vehicle without Levulan in patients with moderate to severe facial acne vulgaris.
Read more...DUSA Announces Results for Phase IIB Trial Of Levulan(R) Photodynamic Therapy for Moderate to Severe Acne (Marketwire via Yahoo! Finance)
DUSA Pharmaceuticals, Inc.® announced today results from its Phase IIB clinical trial to compare the safety and efficacy of photodynamic therapy using DUSA's BLU-U® brand light plus vehicle containing Levulan® to that of PDT using the BLU-U plus vehicle without Levulan in patients with moderate to severe facial acne vulgaris.
Read more...Allergan Reports Third Quarter 2008 Operating Results (Centre Daily Times)
Allergan, Inc. (NYSE:AGN) today announced operating results for the quarter ended September 30, 2008. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2008 to stockholders of record on November 10, 2008.
Read more...